Renaissance Technologies LLC Has $14.18 Million Holdings in Astera Labs, Inc. $ALAB

Renaissance Technologies LLC cut its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 68.2% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 129,401 shares of the company’s stock after selling 277,000 shares during the quarter. Renaissance Technologies LLC’s holdings in Astera Labs were worth $14,182,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. Lido Advisors LLC boosted its position in Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares during the last quarter. Perigon Wealth Management LLC raised its position in shares of Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares in the last quarter. Sound Income Strategies LLC raised its position in shares of Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares in the last quarter. Venturi Wealth Management LLC lifted its stake in shares of Astera Labs by 2.6% in the 4th quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock valued at $546,000 after purchasing an additional 84 shares during the period. Finally, Goldstein Advisors LLC lifted its stake in shares of Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the completion of the sale, the chief executive officer owned 3,929,183 shares in the company, valued at $786,465,269.28. The trade was a 3.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the transaction, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

ALAB stock opened at $311.23 on Friday. The company’s 50-day moving average is $359.97 and its 200-day moving average is $229.78. The stock has a market capitalization of $53.35 billion, a PE ratio of 210.29, a price-to-earnings-growth ratio of 3.47 and a beta of 3.66. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period in the previous year, the company posted $0.33 EPS. The firm’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 1.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. Jefferies Financial Group restated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday. Morgan Stanley boosted their price target on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Roth Capital restated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $284.25.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.